Nova Reports First Quarter 2020 Results, Exceeds Guidance

REHOVOT, Israel, May 14, 2020 /PRNewswire/ -- Nova (Nasdaq: NVMI) today announced financial results for the first quarter ended March 31(st), 2020.

First Quarter 2020 Highlights:

    --  Quarterly revenue of $61.0 million, exceeding guidance of $50 million to
        $60 million.
    --  GAAP net income of $11.7 million, or $0.41 per diluted share, exceeding
        guidance of $0.18 to $0.34 per share.
    --  Non-GAAP net income of $13.5 million, or $0.47 per diluted share,
        exceeding guidance of $0.26 to $0.42 per share.
    --  Balanced product revenue mix across Logic/Foundry and Memory.
    --  Nova's optical metrology solutions selected by leading global logic
        manufacturer for its global logic fabrication sites. Initial revenues
        were recognized in the first quarter of 2020.


                                                                                                                                      
            
              GAAP Results ($K)

                                                                                                                                                       ---

                                                                                                                                                        
            
              Q1 2020         
     
     Q4 2019         
     
     Q1 2019

                                                                                                                                                                                                                              ---


            Revenues                                                                                                                                                               $61,022             $64,625             $56,657

    ---


            Net Income                                                                                                                                                             $11,682             $12,385              $7,756

    ---


            Earnings per Diluted Share                                                                                                                                               $0.41               $0.43               $0.27

    ---

                                                                                                                                  
            
              NON-GAAP Results ($K)

                                                                                                                                                     ---

                                                                                                                                                        
            
              Q1 2020         
     
     Q4 2019         
     
     Q1 2019

                                                                                                                                                                                                                              ---


            Net Income                                                                                                                                                             $13,481             $14,561             $10,449

    ---


            Earnings per Diluted Share                                                                                                                                               $0.47               $0.51               $0.37

    ---




            
              A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements that are
    part of this release. Non-GAAP results exclude amortization of acquired intangible assets, stock-based compensation expenses, facilities
    transition costs, revaluation of long-term liabilities and tax effect of non-GAAP adjustments.

Management Comments

"Nova performed well this quarter with revenue and profitability exceeding the guidance. These financial results demonstrate our solid execution capabilities as well as our resilient and agile operational model, which allows us to adapt quickly to uncertainties in the market," commented Eitan Oppenhaim, President and Chief Executive Officer. "Amid the global spread of the pandemic, our focus continues to be on the safety and well-being of our employees and partners. Although the market is still vulnerable, we have already taken the required measures to protect our production lines and supply chain to ensure business continuity throughout the year."

2020 Second Quarter Financial Outlook

Management provided an outlook for the second quarter, the period ending June 30, 2020. Based on current estimates, management expects:

    --  $58 million to $66 million in revenue
    --  $0.29 to $0.43 in diluted GAAP EPS
    --  $0.37 to $0.51 in diluted non-GAAP EPS

2020 First Quarter Results

Total revenues for the first quarter of 2020 were $61.0 million, a decrease of 6% compared to the fourth quarter of 2019 and an increase of 8% compared to the first quarter of 2019.

Gross margin for the first quarter of 2020 was 56%, compared to a gross margin of 54% in the fourth quarter of 2019, and compared to gross margin of 56% in the first quarter of 2019.

Operating expenses in the first quarter of 2020 were $21.5 million, compared with $20.1 million in the fourth quarter of 2019 and compared with $22.9 million in the first quarter of 2019.

On a GAAP basis, the company reported net income of $11.7 million, or $0.41 per diluted share, in the first quarter of 2020. This is compared with net income of $12.4 million, or $0.43 per diluted share, in the fourth quarter of 2019, and compared with net income of $7.8 million, or $0.27 per diluted share, in the first quarter of 2019.

On a non-GAAP basis, which excludes amortization of acquired intangible assets, stock-based compensation expenses, facilities transition costs, revaluation of long-term liabilities and tax effect of non-GAAP adjustments, the company reported net income of $13.5 million, or $0.47 per diluted share, in the first quarter of 2020. This is compared with net income of $14.6 million, or $0.51 per diluted share, in the fourth quarter of 2019, and compared with net income of $10.4 million, or $0.37 per diluted share, in the first quarter of 2019.

Conference Call Information

Nova will host a conference call today, May 14, 2020, at 9 a.m. Eastern Time, to discuss the financial results and outlook. To attend the conference call, please dial one of the following teleconferencing numbers. Please begin by placing your calls five minutes before the conference call commences. If you are unable to connect using the toll-free numbers, please try the international dial-in number.

U.S. TOLL-FREE Dial-in Number: 1-866-548-4713
ISRAEL TOLL-FREE Dial-in Number: 1-809-212-883
INTERNATIONAL Dial-in Number: 1-323-794-2093

At:
9 a.m. Eastern Time
6 a.m. Pacific Time
4 p.m. Israel Time

Please reference conference ID: 6871888

The conference call will also be webcast live from a link on Nova's website at https://www.novami.com/investors/events/.

A replay of the conference call will be available from May 14, 2020 at 12 p.m. Eastern Time to May 21, 2020 at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers:

Replay Dial-in TOLL-FREE: 1-844-512-2921
Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-6671
Replay Pin Number: 6871888

A replay will also be available for 90 days on Nova's website at https://www.novami.com/investors/events/.

About Nova:

Nova is a leading innovator and key provider of metrology solutions for advanced process control used in semiconductor manufacturing. Nova delivers continuous innovation by providing state-of-the-art high-performance metrology solutions for effective process control throughout the semiconductor fabrication lifecycle. Nova's product portfolio, which combines high- precision hardware and cutting-edge software, provides its customers with deep insight into the development and production of the most advanced semiconductor devices. Nova's unique capability to deliver innovative X-ray and Optical solutions enable its customers to improve performance, enhance product yields and accelerate time to market. Nova acts as a partner to semiconductor manufacturers from its offices around the world. Additional information may be found at www.novami.com.

Nova is traded on the NASDAQ & TASE under the symbol NVMI.

This press release provides financial measures that exclude amortization of acquired intangible assets, stock-based compensation expenses, facilities transition costs, revaluation of long-term liabilities and tax effect of non-GAAP adjustments and are therefore not calculated in accordance with generally accepted accounting principles (GAAP). Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding Nova's performance because they reflect our operational results and enhances management's and investors' ability to evaluate Nova's performance before charges or benefits considered by management to be outside Nova's ongoing operating results. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management believes that it is in the best interest of its investors to provide financial information that will facilitate comparison of both historical and future results and allows greater transparency to supplemental information used by management in its financial and operational decision making. A reconciliation of each GAAP to non-GAAP financial measure discussed in this press release is contained in the accompanying financial tables.

This press release contains forward-looking statements within the meaning of safe harbor provisions of the Private Securities Litigation Reform Act of 1995 relating to future events or our future performance, such as statements regarding, but are not limited to, anticipated growth opportunities and projections about our business and its future revenues, expenses and profitability. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in those forward-looking statements. Factors that may affect our results, performance, circumstances or achievements include, but are not limited to, the following: our dependency on three product lines; our dependency on a small number of large customers and small number of suppliers; the highly cyclical and competitive nature of the markets we target and we operate in; our inability to reduce spending during a slowdown in the semiconductor industry; our ability to respond effectively on a timely basis to rapid technological changes; our dependency on PEMs; risks related to exclusivity obligations and non-limited liability that may be included in our commercial agreements and arrangements; our ability to retain our competitive position despite the ongoing consolidation in our industry; risks related to our dependence on our manufacturing facilities; risks related to changes in our order backlog; risks related to efforts to complete and integrate current and/or future acquisitions; risks related to worldwide financial and economic instabilities, including the implications of the ongoing novel coronavirus (COVID-19) pandemic; risks related to our intellectual property; new product offerings from our competitors; unanticipated manufacturing or supply problems; risks related to government programs we participate in; risks related to taxation; changes in customer demand for our products; risks related to currency fluctuations; risks related to technology security threats, including data breaches, cyberattacks and system disruptions, and changes in privacy laws; risks related to acquisitions we may pursue and risks related to our operations in Israel. We cannot guarantee future results, levels of activity, performance or achievements. The matters discussed in this press release also involve risks and uncertainties summarized under the heading "Risk Factors" in Nova's Annual Report on Form 20-F for the year ended December 31, 2019 filed with the Securities and Exchange Commission on March 12, 2020. These factors are updated from time to time through the filing of reports and registration statements with the Securities and Exchange Commission. Nova Measuring Instruments Ltd. does not assume any obligation to update the forward-looking information contained in this press release

(Tables to Follow)




                                                         
           
         
                  NOVA MEASURING INSTRUMENTS LTD.

                                                                                 ---

                                                      
           
         
                  CONDENSED CONSOLIDATED BALANCE SHEETS

                                                                                 ---

                                                               
       (U.S. dollars in thousands) - (Unaudited)




                                                                                                 
              
                As of




     
                ASSETS                                                                                              March 31, 
     
     December 31,

                                                                                                                            2020               2019




     Current assets



     Cash and cash equivalents                                                                                           35,531             31,748



     Short-term interest-bearing bank deposits                                                                          162,155            154,533



     Trade accounts receivable                                                                                           55,043             51,603



     Inventories                                                                                                         49,779             48,362



     Other current assets                                                                                                13,429             17,122






     
                Total current assets                                                                                  315,937            303,368






     Non-current assets



     Interest-bearing bank deposits                                                                                       2,726              2,813



     Restricted interest-bearing bank deposits                                                                            2,000              2,000



     Deferred tax assets                                                                                                  4,755              4,554



     Severance pay funds                                                                                                  1,158              1,210



     Right of-use assets                                                                                                 27,545             28,256



     Property and equipment, net                                                                                         31,460             30,566



     Intangible assets, net                                                                                               6,936              7,562



     Goodwill                                                                                                            20,114             20,114






     
                Total non-current assets                                                                               96,694             97,075






     
                Total assets                                                                                          412,631            400,443






     
                 LIABILITIES AND SHAREHOLDERS' EQUITY



     Current liabilities



     Trade accounts payable                                                                                              18,451             20,706



     Deferred revenues                                                                                                    2,602              2,256



     Operating lease current liabilities                                                                                  2,020              2,236



     Other current liabilities                                                                                           23,220             21,751






     
                Total current liabilities                                                                              46,293             46,949






     Non-current liabilities



     Accrued severance pay                                                                                                2,054              2,120



     Operating lease long-term liabilities                                                                               30,370             31,077



     Other long-term liability                                                                                            6,025              5,758






     
                Total non-current liabilities                                                                          38,449             38,955






     
                Shareholders' equity                                                                                  327,889            314,539






     
                Total liabilities and shareholders' equity                                                            412,631            400,443




                                            
              
                
                  NOVA MEASURING INSTRUMENTS LTD.

                                                                              ---

                                    
              
                
                  CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                                                                              ---

                                       
              (U.S. dollars in thousands, except per share data) - (Unaudited)




                                                                                                                              Three months ended

                                                                                                                              March 31,



                                                                                                                             2020                  2019






          Revenues:



          Products                                                                                                        45,725                44,061



          Services                                                                                                        15,297                12,596




          Total revenues                                                                                                  61,022                56,657






          Cost of revenues:



          Products                                                                                                        18,040                17,577



          Services                                                                                                         8,640                 7,496




          Total cost of revenues                                                                                          26,680                25,073






          
                Gross profit                                                                                       34,342                31,584





          Operating expenses:



          Research and development, net                                                                                   11,683                12,584



          Sales and marketing                                                                                              6,563                 7,146



          General and administrative                                                                                       2,589                 2,522



          Amortization of acquired intangible assets                                                                         626                   656




          Total operating expenses                                                                                        21,461                22,908






          
                Operating income                                                                                   12,881                 8,676





          Financing income, net                                                                                            1,028                   510






          
                Income before taxes on income                                                                      13,909                 9,186





          Income tax expenses                                                                                              2,227                 1,430






          
                Net income for the period                                                                          11,682                 7,756






          
                Earnings per share:



          Basic                                                                                                             0.42                  0.28




          Diluted                                                                                                           0.41                  0.27






          
                Shares used for calculation of earnings per
    share:





          Basic                                                                                                           27,902                27,932




          Diluted                                                                                                         28,760                28,580


                                                                             
         
           
                  NOVA MEASURING INSTRUMENTS LTD.

                                                                                                     ---

                                                                      
            
         
                CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

                                                                                                     ---

                                                                                 
         (U.S. dollars in thousands) - (Unaudited)




                                                                                                                                                  Three months ended



                                                                                                                                                       March 31,     March 31,

                                                                                                                                                                2020       2019




     Cash flows from operating activities:



     
                Net income for the period                                                                                                                  11,682      7,756





     Adjustments to reconcile net income to net cash


     provided by operating activities:



     Depreciation and amortization                                                                                                                            2,744      2,700



     Stock-based compensation                                                                                                                                 1,318      1,212



     Change in deferred tax assets, net                                                                                                                         654      (197)



     Change in accrued severance pay, net                                                                                                                      (14)        33



     Change in trade accounts receivable                                                                                                                    (3,440)     6,610



     Change in inventories                                                                                                                                  (1,448)   (4,532)



     Change in other current and long-term assets                                                                                                             3,693        602



     Change in trade accounts payable                                                                                                                       (2,255)     3,304



     Change in other current and long-term liabilities                                                                                                          211    (1,122)



     Change in short term deferred revenues                                                                                                                     346      1,134






     
                Net cash provided by operating activities                                                                                                  13,491     17,500






     Cash flow from investment activities:



     Increase in short-term and long-term interest-bearing bank deposits                                                                                    (7,535)   (2,372)



     Purchase of property and equipment                                                                                                                     (2,270)   (1,977)






     
                Net cash used in investment activities                                                                                                    (9,805)   (4,349)






     Cash flows from financing activities:



     Purchases of treasury shares                                                                                                                              (14)



     Shares issued upon exercise of options                                                                                                                     111        106






     
                Net cash provided by financing activities                                                                                                      97        106






     
                Increase in cash and cash equivalents and restricted cash                                                                                   3,783     13,257



     
                Cash and cash equivalents - beginning of period                                                                                            31,748     24,877




     
                Cash and cash equivalents - end of period                                                                                                  35,531     38,134


                                                                                                            
              
                
                  NOVA MEASURING INSTRUMENTS LTD.

                                                                                                                                              ---

                                                                                                       
              
                
                  RECONCILIATION OF GAAP TO NON-GAAP RESULTS

                                                                                                                                              ---

                                                                                                  
              (U.S. dollars in thousands, except percentage and per share data) - (Unaudited)




                                                                                                                                                        
              
                Three months ended



                                                                                                                                                                              March 31,                  December 31,          March 31,
                                                                                                                                                                                                          
               
      2019
                                                                                                                                                                                                    2020



                                                                                                                                                                                                                                          2019

                                                                                                                                                                                                                                           ---


              GAAP gross profit                                                                                                                                                                  34,342                34,633            31,584



              Stock-based compensation expenses *                                                                                                                                                   256                   269               234



              Facilities transition costs                                                                                                                                                             -                                   212



              Non-GAAP gross profit                                                                                                                                                              34,598                34,902            32,030




              
                GAAP gross margin as a percentage of revenues                                                                                                                            56%                  54%              56%



              
                Non-GAAP gross margin as a percentage of revenues                                                                                                                        57%                  54%              57%





              GAAP operating income                                                                                                                                                              12,881                14,483             8,676



              Stock-based compensation expenses *                                                                                                                                                 1,318                 1,430             1,212



              Amortization of acquired intangible assets                                                                                                                                            626                   656               656



              Facilities transition costs                                                                                                                                                             -                                   614



              Non-GAAP operating income                                                                                                                                                          14,825                16,569            11,158




              
                GAAP operating margin as a percentage of revenues                                                                                                                        21%                  22%              15%



              
                Non-GAAP operating margin as a percentage of revenues                                                                                                                    24%                  26%              20%





              GAAP net income                                                                                                                                                                    11,682                12,385             7,756



              Stock-based compensation expenses *                                                                                                                                                 1,318                 1,430             1,212



              Amortization of acquired intangible assets                                                                                                                                            626                   656               656



              Facilities transition costs                                                                                                                                                             -                                   614



              Revaluation of long-term liabilities                                                                                                                                                 (66)                  269               484



              Tax effect of non-GAAP adjustments                                                                                                                                                   (79)                (179)            (273)



              Non-GAAP net income                                                                                                                                                                13,481                14,561            10,449






              GAAP basic earnings per share                                                                                                                                                        0.42                  0.44              0.28




              Non-GAAP basic earnings per share                                                                                                                                                    0.48                  0.52              0.37






              GAAP diluted earnings per share                                                                                                                                                      0.41                  0.43              0.27




              Non-GAAP diluted earnings per share                                                                                                                                                  0.47                  0.51              0.37






              Shares used for calculation of earnings per share:



              Basic                                                                                                                                                                              27,902                27,965            27,932




              Diluted                                                                                                                                                                            28,760                28,689            28,580






              * Stock-based compensation expenses for the three months ended March 31, 2020 included in - Cost of revenues
    products - 206; Cost of revenues services - 50; Research and development expenses, net - 335; Sales and marketing
    expenses - 346; General and administrative expenses - 381.



              
                Company Contact:       
             
                Investor Relations Contact:


              Dror David, Chief Financial Officer 
             
              Miri Segal
    Nova Measuring Instruments Ltd.                MS-IR LLC
    Tel: +972-73-229-5760                          
             Tel: +917-607-8654

              E-mail: info@novami.com             
             E-mail: msegal@ms-ir.com
    www.novami.com

    ---

View original content:http://www.prnewswire.com/news-releases/nova-reports-first-quarter-2020-results-exceeds-guidance-301059308.html

SOURCE Nova